Physician profile
Irving Edelsberg
NPI 1124004866
$2,113.10
in general payments reported to CMS, 2019-2025
16 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $203 · 2021: $103 · 2022: $430 · 2023: $354 · 2024: $360 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $404.26 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $367.56 | 2019-2025 | Clareon, Tryptyr |
| Allergan, INC. | $268.81 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $220.30 | 2023 | Miebo |
| Biotissue Holdings INC. | $206.07 | 2022-2024 | |
| Glaukos Corporation | $123.89 | 2022 | |
| Sight Sciences, INC. | $80.33 | 2019 | |
| Coopervision INC. | $76.17 | 2023-2024 | Misight Contact Lens, Myday Contact Lens |
| Maculogix, INC. | $73.78 | 2019 | |
| Visioneering Technologies, INC. | $62.50 | 2019 | |
| Dompe US, INC. | $55.00 | 2025 | Oxervate |
| Menicon America INC | $47.53 | 2019-2020 | |
| Carl Zeiss Meditec, INC. | $45.69 | 2019 | |
| Genzyme Corporation | $43.88 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.93 | 2024 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irving Edelsberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.